TATVA · NSE

Tatva Chintan Pharma Chem Limited

₹1,770.2

+3.54% (+₹60.6)

Prev. close

₹1,709.6

Volume

91,966

Delivery %

43.1%

As of

18 Sept 2026

Price history

₹1,770.2+₹656.5 (+58.95%) · 3M
10 Jun 202618 Sept 2026
₹1,800.1₹1,113.710 Jun03 Jul03 Aug26 Aug18 Sept
Daily closes · updates after each session

No analyst calls on this stock in the last 90 days yet.

Explore by date range →

Analyst opinions

No analyst calls on Tatva Chintan Pharma Chem Limited in the last 90 days.

Fundamentals

About Tatva Chintan Pharma Chem Limited

Tatva Chintan Pharma Chem Limited engages in the manufacture and sale of specialty chemicals in India, Germany, the United States of America, China, Singapore, and internationally. It offers structure directing agents (SDAs); phase transfer catalysts (PTCs); electrolyte salts for super capacitor batteries; pharmaceutical and agrochemical intermediates, and other specialty chemicals (PASC); and brominated flame retardants. The company serves automotive, consumer electronics, pharmaceutical, agrochemicals, paints and coatings, dyes, and personal care sectors. Tatva Chintan Pharma Chem Limited was incorporated in 1996 and is headquartered in Vadodara, India.

Details

Sector

Basic Materials

Industry

Specialty Chemicals

CEO

Mr. Chintan Nitinkumar Shah

Headquarters

Vadodara

Employees

793

Key stats

Market cap

₹4,140.86 Cr

P/E ratio (TTM)

80.6

Dividend yield

0.11%

EPS (TTM)

₹21.95

Beta (1Y · daily vs NIFTY 50)

1.26

Beta (5Y · monthly vs NIFTY 50)

1.26

Shares float

60.47 L

EPS · quarter ended Jun 2026

₹6.83

Financial Performance

01 · Financials

0 Cr200 Cr400 Cr600 Cr-20%0%20%40%FY21FY22FY23FY24FY25FY26
RevenueRevenue growth YoY

FY21 growth needs FY20 filings, which the data source doesn't provide. Net income and EBITDA are omitted from this chart: coverage begins inside the plotted window, and every plotted period must carry a complete point set — the P&L table below has the available figures.

02 · Earnings Per Share (EPS)

0204060FY22FY23FY24FY25FY26

03 · Dividend Profile

01122-50%-25%0%25%08 Sept 2208 Sept 2306 Sept 2412 Sept 2511 Sept 26
Dividend (₹/share)Annualised yieldAnnual dividend growth (FY)

Growth compares completed fiscal-year dividend totals on the company's own calendar: April–March (Indian FY), taken from its reported period-ends. Payout ledger: NSE corporate actions.

04 · Operating Efficiency (Growth Rates)

Balance-sheet-based

-100%0%100%200%FY21FY22FY23FY24FY25FY26
SalesFixed assetsReceivables (trade + unbilled)Inventory

05 · Capital Structure & Asset Utilization

0 Cr500 Cr1000 Cr1500 Cr0.25×0.5×0.75×FY21FY22FY23FY24FY25FY26
Total assetsTotal debtDebt / equityAsset turnover

Asset turnover needs a prior year of assets — omitted for the earliest available year.

06 · Asset Base Composition

0 Cr500 Cr1000 Cr1500 CrFY21FY22FY23FY24FY25FY26
Fixed assetsCurrent assetsOther assets

07 · Debt Level & Coverage

-200 Cr-100 Cr0 Cr100 Cr200 CrFY21FY22FY23FY24FY25FY26
DebtFree cash flowCash & equivalents

08 · Profit & Loss

Annual

Line itemFY21FY22FY23FY24FY25FY26
₹433.65 Cr₹423.61 Cr₹393.50 Cr₹382.71 Cr₹505.86 Cr
EBITDA₹117.13 Cr₹62.74 Cr₹75.71 Cr₹36.53 Cr₹96.71 Cr
₹95.87 Cr₹45.49 Cr₹30.35 Cr₹5.71 Cr₹42.05 Cr
Diluted EPS₹44.59₹20.52₹13.26₹2.44₹17.98

Revenue, Total expenses (as filed), Employee benefit expense, Depreciation & amortisation, Other expenses, EBITDA, Net income, Pretax income, Tax provision, Interest expense, Other income, Diluted EPS have filed figures for only some of the years shown — the missing years are left blank rather than estimated.

09 · Balance Sheet

Annual

Line itemFY21FY22FY23FY24FY25FY26
₹314.80 Cr₹658.06 Cr₹756.30 Cr₹818.72 Cr₹836.25 Cr₹1,003.69 Cr
₹119.94 Cr₹170.26 Cr₹14.27 Cr₹36.39 Cr₹120.37 Cr
Stockholders' equity₹165.96 Cr₹473.09 Cr₹514.79 Cr₹737.08 Cr₹738.82 Cr₹781.76 Cr

Total debt, Long-term debt, Current (short-term) debt, Others have filed figures for only some of the years shown — the missing years are left blank rather than estimated.

Annual only — the data source doesn’t publish quarterly balance-sheet detail for most NSE-listed companies.

10 · Cash Flow Statement

Annual

Line itemFY21FY22FY23FY24FY25FY26
₹20.38 Cr₹27.78 Cr₹98.04 Cr₹24.67 Cr₹31.49 Cr
Investing cash flow₹-196.81 Cr₹-101.14 Cr₹-120.54 Cr₹-65.25 Cr₹-115.84 Cr
₹234.96 Cr₹37.80 Cr₹30.52 Cr₹16.57 Cr₹78.93 Cr
Capital expenditure₹-89.16 Cr₹-203.11 Cr₹-128.52 Cr₹-76.27 Cr₹-113.77 Cr
End cash position₹4.48 Cr₹63.02 Cr₹27.37 Cr₹35.30 Cr₹11.37 Cr₹5.76 Cr

Operating cash flow, Depreciation & amortization, Change in working capital, Investing cash flow, Financing cash flow, Debt issued, Debt repaid, Dividends paid, Capital expenditure have filed figures for only some of the years shown — the missing years are left blank rather than estimated.

Annual only — the data source has no quarterly cash-flow-statement coverage.

11 · Shareholding Pattern

NSE, quarterly

Line itemSep 21Jun 23(8Q)Aug 23Sep 23Jun 26(12Q)
Promoter79.17%75.02%72.02%
Public20.83%24.98%27.98%
Employee trusts0.00%0.00%0.00%

Source: NSE quarterly shareholding-pattern filings, collapsed to periods where the reported percentages held steady — a column spanning several quarters means no change was filed across them. No FII/DII sub-split available from this source — Public includes all non-promoter, non-employee-trust holders.

12 · Peer Comparison

Basic Materials

Company
UltraTech Cement Limited₹3.17 L Cr₹11,01436.94.1310.7%0.31+16.6%-12.8%
JSW Steel Limited₹3.06 L Cr₹1,275.612.43.0622.3%1.19+9.3%+13.8%
Hindustan Zinc Limited₹2.42 L Cr₹59614.210.6961.1%0.39+18.6%+31.0%
Asian Paints Limited₹2.35 L Cr₹2,451.349.311.0120.2%0.18+5.1%-1.1%
Tata Steel Limited₹2.28 L Cr₹187.2920.72.2310.6%0.90+6.2%+9.3%
Hindalco Industries Limited₹2.18 L Cr₹986.513.31.599.8%0.73+15.0%+31.5%
Grasim Industries Limited₹2.15 L Cr₹3,209.237.92.084.8%2.20+18.2%+11.5%
Solar Industries India Limited₹1.71 L Cr₹18,81586.127.2526.7%0.29+30.6%+27.0%
Vedanta Aluminium Metal Limited₹1.60 L Cr₹416.542.1
Pidilite Industries Limited₹1.58 L Cr₹1,572.159.814.5822.6%0.04+11.1%-48.5%
JINDAL STEEL LIMITED₹1.11 L Cr₹1,10341.12.196.6%0.44+5.5%+4.7%
Tatva Chintan Pharma Chem Limited₹3,991.62 Cr₹1,709.673.05.115.4%0.15+31.8%+54.4%

Ranked by market cap within Basic Materials, same metrics as the Fundamentals screener. Click a column to sort.

Documents

TATVA

Tatva Chintan turns a buy case as momentum and earnings improve

Indiatimes · 3 days ago

TATVA

Tatva Chintan posts sharp FY26 profit jump on stronger sales

ET Chemicals · 5 days ago